Welcome to the 2nd RNA Assay Development & Screening Summit 2024!

The 2nd RNA Assay Development & Screening Summit 2024 is returning to Boston with 3 jam-packed days of exciting content and discussions, this meeting will showcase novel and innovative assays, screening methods and strategies for identifying new RNA targets, validating RNA-small molecule interactions and unlocking the potential of targeting RNA binding proteins to accelerate the discovery of RNA-targeting drugs.

Why Attend?

47801 - Favicon (1)

Uncover biophysical screening strategies for improved understanding of RNA-small molecule interactions to accelerate hit identification with Molecure & AbbVie

47801 - Favicon (2)

Explore innovative assays to understand the mechanism of action of small molecule drugs for improved selection of potent lead candidates with Biogen, NextRNA Therapeutics & Remix Therapeutics

47801 - Favicon (6)

Accelerate identification of selective RNA binders through novel screening and assay strategies for fast-tracking more effective drugs towards the clinic with Arrakis Therapeutics, Atavistik Bio & Wayfinder Biosciences

47801 - Favicon (7)

Leverage omic-based methods and screening strategies to understand the effects of targeting RNA binding proteins to widen the landscape of disease targets with Accent Therapeutics, University of Texas at Austin & University of California San Diego

47801 - Favicon (9)

Overcome RNA’s dynamic nature by optimizing tools to accurately understand the RNA target structure to improve characterization of druggable pockets with Expansion Therapeutics & CHDI Management

What's in Store for 2024?




Expert Speakers


Data Driven Presentations




Panel Discussion


Interactive Fireside Chat

Hear What our Expert Speakers Have to Say: